不同温度及保存时间对糖化血红蛋白检测结果的影响

黄艳萍, 祝峰

武警医学 ›› 2018, Vol. 29 ›› Issue (9) : 868-870.

PDF(501 KB)
PDF(501 KB)
武警医学 ›› 2018, Vol. 29 ›› Issue (9) : 868-870.
论 著

不同温度及保存时间对糖化血红蛋白检测结果的影响

  • 黄艳萍, 祝峰
作者信息 +

Effect of specimen disposal on detection of glycosylated hemoglobin by OLIMPO specific protein analyzer

  • HUANG Yanping and ZHU Feng.
Author information +
文章历史 +

摘要

目的 探讨标本在不同温度及不同保存时间的条件下,对糖化血红蛋白(HbA1c)检测结果的影响。方法 取10例患者抗凝新鲜全血标本进行预处理(溶血处理),在室温下分装成6组,每组10个标本。A组立即检测,B、C、D、E、F组分别在分装后1、2、3、4、5 h检测。取5例全血标本分别充分混匀后,分4组保存,每组5个标本。A1组在室温(18~22 ℃)、B1组冷藏(2~8 ℃)、C1组冷冻(-18~-20 ℃)、 D1组低温冷冻(-80 ℃)条件下保存不同时间后,分别用OLIMPO进行检测。以低温冷冻组测定结果为标准,每个标本的HbA1c测定结果都在低温冷冻组结果的±3s范围内为可接受结果。结果 溶血后不同时间HbA1c检测结果:A组(7.98±1.61)%;B组(7.97±1.61)%;C组(7.95±1.60)%;D组(7.94±1.61)%;E组(7.77±1.61)%;F组(7.46±1.57)%。与A组比较,F组差异有统计学意义(t=1.57,P<0.05)。要使OLIMPO检测HbA1c结果保持稳定,则标本的保存时间分别为:室温2 d,冷藏15 d,冷冻3 d;低温冷冻半年以上。结论 OLIMPO检测HbA1c时,不同处理条件下,HbA1c结果的稳定性差异较大。样本溶血处理后4 h内完成检测,结果较准确;如果全血标本需要保存较长的时间,则在2~8 ℃冷藏和-80 ℃条件下保存效果较好。

Abstract

Objective To explore the effect of sample hemolysis time and preservation conditions on the detection of glycosylated hemoglobin (HbA1c) by OLIMPO.Methods 1.Anticoagulant samples of fresh whole blood were taken from ten patients to be preprocessed (hemolyzed). Sixty samples of 150 μl each were collected and equally divided into 6 groups at room temperature. Group A was immediately detected, while groups B, C, D, E and F were detected 1, 2, 3, 4 and 5 hours later, respectively. 2. After 5 samples of whole blood were mixed properly, they were divided into 4 groups with 5 samples in each. Group A1 was stored at room temperature (18-22 ℃), group B1 was refrigerated (2-8 ℃), group C1 cryopreserved (-18--20 ℃) , and group D1 was cryopreserved at a low temperature (below -80 ℃).The results of D1 were taken as the standard to detect the quality of each group with OLIMPO. The HbA1c results of each specimen were regarded as acceptable if they were within the range of ±3 compared with the results of D1.Results 1.HbA1c results at different time points after hemolysis were (7.98±1.61)% in group A, (7.97±1.61)% in group B, (7.95±1.60)% in group C, (7.94±1.61)% in group D, (7.77±1.61)% in group E and (7.46±1.57)% in group F. There was statistically significant difference between group A and group F (t=1.57,P<0.05). 2. In order to keep HbA1c results stable during OLIMPO test, the storage time of samples was 2D at room temperature, 15 d for cold storage, 3D for cryopreservation and more than half a year for cryopreservation at a low temperature.Conclusions When HbA1c is detected with OLIMPO, the stability varies considerably under different processing conditions. The results are relatively accurate within 4 hours after sample hemolysis. If the whole blood sample specimen needs to be stored for a longer time (for scientific research or re examination), better preservation can be achieved at 2-8 ℃ and -80 ℃.

关键词

溶血时间 / 保存温度 / 保存时间 / HbA1c / OLIMPO 特定蛋白分析仪

Key words

hemolysis time / storage temperature / storage time / glycosylated hemoglobin / OLIMPO protein analyzer

引用本文

导出引用
黄艳萍, 祝峰. 不同温度及保存时间对糖化血红蛋白检测结果的影响[J]. 武警医学. 2018, 29(9): 868-870
HUANG Yanping and ZHU Feng.. Effect of specimen disposal on detection of glycosylated hemoglobin by OLIMPO specific protein analyzer[J]. Medical Journal of the Chinese People Armed Police Forces. 2018, 29(9): 868-870
中图分类号: R446.1   

参考文献

[1] Howaed J A,Sommers R,Could O N,et al.Effectiveness of an HbA1c tracking tool on primary care management of diabetes mellitus glycaemic control,clinical practice and usability[J].Inform Prim Care,2009,17(1):41-46.
[2] Sacks D B,Arnold M,Bakris G L, et al.Guidelines and recommendations forlaboratory analysis in the diagnosis and management of diabetes mellitus[J].Clin Chem,2011,57(6):e1-e47.
[3] 王 彦,张 葵,徐志晔,等. 标本保存条件对Tosoh G7糖化血红蛋白分析仪测定结果稳定性的影响[J].临床检验杂志,2014,32(4):299-300.
[4] RoMfing C L,Hanson S,Tennill A J,et al.Effects of whole blood storage on hemoglobin al cmeasurements with five current assay methMs[J].Diabetes Technol Ther,2012,14(3):271-275.
[5] Little R R,Rohlfmg C L,Wiedmeyer H M,et al.The national glycohemoglobin standardization program:a five-year progress report[J].Clin Chem,2001,47(11):1985-1992.
[6] World Health Organization.Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation[R].Geneva,World Health Organization,2006:2-8
[7] 孔亚坤,耿秀琴,周艳红,等.甘精胰岛素与西格列汀联用治疗口服降糖药控制不佳的老年 2 型糖尿病的有效性和安全性[J]. 中国药师, 2016,19(4):695-697.
[8] 李道鸿,徐 晓,杨旭枫,等 .不同治疗方法对老年冠心病合并 2 型 糖尿病患者血糖控制前后生长分化因子15、hs-CRP 的影响[J].中国循证心血管医学杂志,2016,8(9):1053-1055.
[9] American Diabetes Association. Diagnosis and classification of diabete mellitus[J]. Diabetes care,2010,33:s62-69.
[10] World Health Organization. Use of glycated haemoglobin(HbA1c) in the diagnosis of diabetes mellitus:abbreviated report of a WHO consultation[R]. Geneva:WHO,2011:11.
[11] American Diabete Association.Standards of medical care in diabetes-2016:summary of revisions[J]. Diabetes Care,2016,39(Suppl 1.1):S4-S5.
[12] 张秀明,阚丽娟. 影响糖化血红蛋白测定的因素及实验室检测注意事项[J].中华检验医学杂志,2014,37(12):893-895.

PDF(501 KB)

Accesses

Citation

Detail

段落导航
相关文章

/